Chen Tianyan is M.D. and research fellow and doctoral tutor.

Member  Bacterial and Fungal Infection Group of Chinese Society of Infectious Diseases

Member   Clinical Microbiology and Infection Society of China International Exchange and Promotion Association for Medical and Healthcare

Member   Working Committee of Rational Use of Antimicrobial Drugs of Chinese Hospital Association

Standing Committee Member   Professional Committee of Hepatology of China Medical Education Association

Member   Tuberculous Meningitis Branch of Professional Committee of Tuberculosis of Chinese Medical Association

Member  Professional Committee of Infectious Diseases of Beijing Medical Award Foundation

Director   Professional Committee for Prevention and Treatment of Mother-to-Child Transmission of Infectious Diseases of Shaanxi Province Health Care Association

Deputy Director   Infectious Diseases Society of Shaanxi Medical Doctor Association

Standing Committee Member   Committee of Prevention and Treatment of Liver Diseases of Shaanxi Province Health Care Association

Head  Mother-to-Child Transmission of Hepatitis B Blockage Group

Member and Secretary   Shaanxi Infectious Diseases Association

Chen Tianyan received the first prize of Science and Technology Achievement Award of Shaanxi Province in 2009, the second prize of Science and Technology Achievement Award of Shaanxi Province in 2018 and the first prize of New Treatment and New Medical Technology of XJTU in 2015 entitled Key risk factors of mother-to-child transmission of HBV and establishment of individualized blockage integration technology.

She has undertaken and participated in Major Projects for Infectious Disease in the national 11^th Five-Year Plan, 12^th Five-Year Plan and 13^th Five-Year Plan, hosted several National Natural Science Foundation of China projects, and research projects at the provincial and ministerial levels. She has published more than 20 academic papers in SCI-indexed journals as the first or corresponding author. Her academic papers have been cited by EASL and APASL. She has attended international conferences for academic exchanges for many times. She has received over 2 million Yuan of funding support.

1. Efficacy and safety of telbivudine and tenofovir disoproxil fumarate in preventing hepatitis B vertical transmission: A real-life practice. J Viral Hepat. 2019 Oct;26(10):1170-1177

2. Tenofovir plus hepatitis B immunoglobulin treatment resulted in a rapid HBV DNA load decline in high-risk pregnant women who missed the optimal time window of antiviral prophylaxis. Antivir Ther. 2019;24(2):125-131

3. Safety and efficacy of sofosbuvir based treatment of acute hepatitis C in end-stage renal disease patients undergoing haemodialysis. Aliment PharmacolTher. 2018 Feb;47(4):526-532

4. Baseline Hepatitis B Virus Titer Predicts Initial Postpartum Hepatic Flare: A Multicenter ProspectiveStudy.J Clin Gastroenterol. 2018 Nov/Dec;52(10):902-907

5. No response to hepatitis B vaccine in infants born to HBsAg(+) mothers is associated to the transplacental transfer of HBsAg. Infect Dis (Lond). 2017 ;49(8)：576-583.

6. Hepatic flare after telbivudine withdrawal and efficacy of postpartum antiviral therapy for pregnancies with chronic HBV. J Gastroenterol Hepatol. SCI 2017 ;32(1)：177-183

7. Efficacy of tenofovir disoproxil fumarate to prevent vertical transmission in mothers with lamivudine-resistant HBV. Antivir Ther. 2015;20(7)：681-7

8. An ”immune barrier” is formed in the placenta by hepatitis B immunoglobulin to protect the fetus from hepatitis B virus infection from the mother. Hum Vaccin Immunother. 2015 ;11(8)：2068-76.

9. Dynamic changes of HBV markers and HBV DNA load in infants born to HBsAg(+) mothers: can positivity of HBsAg or HBV DNA at birth be an indicator for HBV infection of infants? BMC Infect Dis. SCI 2013；6（13）：524-530

Nucleoside analogues improve the short-term and long-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure. Clin Exp Med. SCI 2012；12(3)： 159-64.

Chen Tianyan has achieved the first prize of Science and Technology Achievement Award of Shaanxi Province in 2009, the second prize of Science and Technology Achievement Award of Shaanxi Province in 2018, and Science and Technology Award for Young Scholars of Shaanxi Province in 2014. She has obtained the title of Top 10 Physicians, Excellent Teachers and Excellent Teachers for Resident Physician Training of the First Affiliated Hospital of XJTU. She also obtained Advanced Individuals with Medical Moral Ethics of the First Affiliated Hospital of XJTU for several times, and the second prize of Teaching Competition of XJTU.